数据驱动的老年急性髓系白血病患者原始细胞分化的流式细胞术分类 - Suppr

Data-driven flow cytometry classification of blast differentiation in older patients with acute myeloid leukemia.

作者信息

Simoes Catia, Gonzalez Carmen, Vergez François, Sarry Audrey, Bertoli Sarah, Ariceta Beñat, Martínez-Cuadrón David, Bergua Juan-Miguel, Vives Susana, Algarra Lorenzo, Tormo Mar, Martinez Pilar, Serrano Josefina, Herrera Pilar, Ramos Fernando, Salamero Olga, Lavilla Esperanza, Gil Cristina, Lopez-Lorenzo Jose-Luis, Vidriales Maria-Belen, Chillon Carmen, Labrador Jorge, Falantes Jose-Francisco, Sayas María-José, Ayala Rosa, Martinez-Lopez Joaquin, Villar Sara, Calasanz Maria-Jose, Prosper Felipe, San-Miguel Jesús F, Sanz Miguel Á, Récher Christian, Paiva Bruno, Montesinos Pau

机构信息

Cancer Center Clinica Universidad de Navarra, CIMA Universidad de Navarra, IDISNA, CIBER-ONC number CB16/12/00369 and CB16/12/00489, Pamplona, Spain.

Laboratoire d'Hématologie, Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France.

出版信息

Blood Neoplasia. 2024 Jun 19;1(3):100027. doi: 10.1016/j.bneo.2024.100027. eCollection 2024 Sep.

DOI:10.1016/j.bneo.2024.100027

PMID:40453058

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12082131/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4efc/12082131/67fa662d1253/BNEO_NEO-2024-000225-gr1a.jpg

相似文献

Data-driven flow cytometry classification of blast differentiation in older patients with acute myeloid leukemia.数据驱动的老年急性髓系白血病患者原始细胞分化的流式细胞术分类

Blood Neoplasia. 2024 Jun 19;1(3):100027. doi: 10.1016/j.bneo.2024.100027. eCollection 2024 Sep.

Technological features of blast identification in the cerebrospinal fluid: A systematic review of flow cytometry and laboratory haematology methods.脑脊液爆裂物鉴定的技术特征：流式细胞术和实验室血液学方法的系统评价。

Int J Lab Hematol. 2022 Sep;44 Suppl 1(Suppl 1):45-53. doi: 10.1111/ijlh.13869. Epub 2022 Jul 4.

Role of extracellular vesicles as promotors for activation of leukemia‑derived dendritic cell‑mediated antileukemic immune response against AML‑blasts.细胞外囊泡作为促进白血病衍生树突状细胞介导的针对急性髓系白血病原始细胞的抗白血病免疫反应激活剂的作用。

Oncol Rep. 2025 Aug;54(2). doi: 10.3892/or.2025.8932. Epub 2025 Jun 20.

Prediction of relapse of pediatric acute myeloid leukemia by use of multidimensional flow cytometry.运用多参数流式细胞术预测儿童急性髓系白血病的复发

J Natl Cancer Inst. 1996 Oct 16;88(20):1483-8. doi: 10.1093/jnci/88.20.1483.

Sudden blast phase in pediatric chronic myeloid leukemia-chronic phase with abnormal lymphoid blasts detected by flow cytometry at diagnosis: Can it be considered a warning sign?儿童慢性髓性白血病-慢性期中伴有流式细胞术检测到的异常淋巴母细胞 blast 的骤发期：它能被视为一个警告信号吗？

Cytometry B Clin Cytom. 2021 May;100(3):345-351. doi: 10.1002/cyto.b.21958. Epub 2020 Oct 8.

NRF2 maintains redox balance via ME1 and NRF2 inhibitor synergizes with venetoclax in NPM1-mutated acute myeloid leukemia.NRF2通过ME1维持氧化还原平衡，且NRF2抑制剂与维奈托克在NPM1突变的急性髓系白血病中具有协同作用。

Cancer Metab. 2025 Jun 18;13(1):32. doi: 10.1186/s40170-025-00401-6.

[The specific features of diagnosis of mixed-phenotype acute leukemia: A combination of B-cell antigen expressions according to the results of flow cytometry and morphological markers of myeloid differentiation in blast cells: A clinical case].[混合表型急性白血病的诊断特点：根据流式细胞术结果的B细胞抗原表达与原始细胞中髓系分化形态学标志物的结合：1例临床病例]

Ter Arkh. 2015;87(7):97-100. doi: 10.17116/terarkh201587797-100.

Asciminib plus dasatinib and prednisone for Philadelphia chromosome-positive acute leukemia.阿西替尼联合达沙替尼及泼尼松治疗费城染色体阳性急性白血病

Blood. 2025 Feb 6;145(6):577-589. doi: 10.1182/blood.2024025800.

Prognostic Importance of C-KIT Mutations in Core Binding Factor Acute Myeloid Leukemia: A Systematic Review.核心结合因子急性髓系白血病中C-KIT突变的预后重要性：一项系统综述

Hematol Oncol Stem Cell Ther. 2017 Mar;10(1):1-7. doi: 10.1016/j.hemonc.2016.08.005. Epub 2016 Sep 3.

Characteristics, outcomes and treatment patterns in acute myeloid leukemia patients 60 years or older in Colombia: a RENEHOC-PETHEMA study.哥伦比亚60岁及以上急性髓系白血病患者的特征、结局及治疗模式：一项RENEBOC-PETHEMA研究

Ann Hematol. 2025 Jan;104(1):369-381. doi: 10.1007/s00277-024-06120-0. Epub 2025 Jan 16.

引用本文的文献

Measurable residual disease (MRD) as a surrogate end point for clinical drug approval in acute myeloid leukemia (AML): Perspectives from the MRD Partnership and Alliance in AML Clinical Treatment Consortium.可测量残留病（MRD）作为急性髓系白血病（AML）临床药物批准的替代终点：AML临床治疗联盟MRD合作与联盟的观点

Cancer. 2025 Jul 1;131(13):e35960. doi: 10.1002/cncr.35960.

本文引用的文献

Identification of the Thyrotropin-Releasing Hormone (TRH) as a Novel Biomarker in the Prognosis for Acute Myeloid Leukemia.鉴定促甲状腺素释放激素（TRH）作为急性髓系白血病预后的新型生物标志物。

Biomolecules. 2022 Sep 23;12(10):1359. doi: 10.3390/biom12101359.

Phenotypically-defined stages of leukemia arrest predict main driver mutations subgroups, and outcome in acute myeloid leukemia.表型定义的白血病缓解阶段可预测急性髓系白血病的主要驱动基因突变亚组和结局。

Blood Cancer J. 2022 Aug 16;12(8):117. doi: 10.1038/s41408-022-00712-7.

Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN.成人 AML 的诊断与治疗：ELN 专家组代表发布的 2022 年国际专家建议

Blood. 2022 Sep 22;140(12):1345-1377. doi: 10.1182/blood.2022016867.

International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data.国际髓系肿瘤和急性白血病分类：整合形态学、临床和基因组数据。

Blood. 2022 Sep 15;140(11):1200-1228. doi: 10.1182/blood.2022015850.

The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms.世界卫生组织血液淋巴肿瘤分类第五版：髓系和组织细胞/树突状肿瘤。

Leukemia. 2022 Jul;36(7):1703-1719. doi: 10.1038/s41375-022-01613-1. Epub 2022 Jun 22.

A cellular hierarchy framework for understanding heterogeneity and predicting drug response in acute myeloid leukemia.一种用于理解急性髓系白血病异质性和预测药物反应的细胞层次结构框架。

Nat Med. 2022 Jun;28(6):1212-1223. doi: 10.1038/s41591-022-01819-x. Epub 2022 May 26.

Efficacy of front-line immunochemotherapy for follicular lymphoma: a network meta-analysis of randomized controlled trials.一线免疫化疗治疗滤泡性淋巴瘤的疗效：一项随机对照试验的网络荟萃分析。

Blood Cancer J. 2022 Jan 5;12(1):1. doi: 10.1038/s41408-021-00598-x.

The Mutational Landscape of Acute Myeloid Leukaemia Predicts Responses and Outcomes in Elderly Patients from the PETHEMA-FLUGAZA Phase 3 Clinical Trial.急性髓系白血病的突变图谱可预测PETHEMA-FLUGAZA 3期临床试验中老年患者的反应和预后。

Cancers (Basel). 2021 May 18;13(10):2458. doi: 10.3390/cancers13102458.

A phase 3 trial of azacitidine versus a semi-intensive fludarabine and cytarabine schedule in older patients with untreated acute myeloid leukemia.一项比较阿扎胞苷与半强化氟达拉滨和阿糖胞苷方案治疗未经治疗的老年急性髓系白血病患者的 3 期临床试验。

Cancer. 2021 Jun 15;127(12):2003-2014. doi: 10.1002/cncr.33403. Epub 2021 Feb 24.

Plasmacytoid dendritic cell expansion defines a distinct subset of RUNX1-mutated acute myeloid leukemia.浆细胞样树突状细胞扩增定义了一组独特的 RUNX1 突变急性髓系白血病亚群。

Blood. 2021 Mar 11;137(10):1377-1391. doi: 10.1182/blood.2020007897.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Data-driven flow cytometry classification of blast differentiation in older patients with acute myeloid leukemia.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献